SCHEMBL6985755

SCHEMBL6985755

CN(C)CCN1C(=O)CN=C(c2ccccc2)c2ccccc21

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.65
GABRG2 P18507 1/20 0.65
GABRB3 P28472 1/20 0.65
GABRA5 P31644 1/20 0.65
CCKBR P32239 1/20 0.65
GABRA3 P34903 1/20 0.65
GABRA2 P47869 1/20 0.65
GABRB2 P47870 1/20 0.65
HDAC3 O15379 1/20 0.60
HDAC1 Q13547 1/20 0.60
HDAC8 Q9BY41 1/20 0.60
HDAC6 Q9UBN7 1/20 0.60
NPSR1 Q6W5P4 2/20 0.60
GAA P10253 2/20 0.60
HTT P42858 1/20 0.60
GPR55 Q9Y2T6 1/20 0.60
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
MAPT P10636 3/20 0.56
ALDH1A1 P00352 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8851595 0.87 GABRA1 (0.68) GABRA1GABRG2GABRB3GABRA5CCKBR
SCHEMBL7541208 0.84 GABRA1 (0.68) GABRA1GABRG2GABRB3GABRA5CCKBR
SCHEMBL9380657 0.84 HDAC3 (0.69) GABRA1GABRG2GABRB3GABRA5CCKBR
SCHEMBL11576361 0.82 GABRA1 (0.62) GABRA1GABRG2GABRB3GABRA5CCKBR
SCHEMBL11576814 0.82 GABRA1 (0.61) GABRA1GABRG2GABRB3GABRA5CCKBR
SCHEMBL11577126 0.81 GABRA1 (0.61) GABRA1GABRG2GABRB3GABRA5CCKBR
SCHEMBL23560411 0.81 GABRA1 (0.63) GABRA1GABRG2GABRB3GABRA5CCKBR
SCHEMBL4413309 0.81 GABRA1 (0.63) GABRA1GABRG2GABRB3GABRA5CCKBR
SCHEMBL27562818 0.80 NPSR1 (0.78) GABRA1GABRG2GABRB3GABRA5CCKBR
SCHEMBL5360023 0.80 HDAC3 (0.61) GABRA1GABRG2GABRB3GABRA5CCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0730454-A4 ANTIARRHYTHMIC BENZODIAZEPINES MERCK & CO INC (US) 2003-06-04 EP disclosed
EP-0907644-A4 PHARMACEUTICAL PREPARATION MERCK & CO INC (US) 2003-02-05 EP disclosed
EP-0907644-A1 PHARMACEUTICAL PREPARATION Merck & Co., Inc. (US) 1999-04-14 EP disclosed
US-5817658-A ADMINISTERING A DIAZEPINE COMPOUND; DISEASES OF THE EAR MERCK & COMPANY, INC. (US) 1998-10-06 US disclosed
US-5776930-A CARDIOVASCULAR DISORDERS MERCK & COMPANY, INC. (US) 1998-07-07 US disclosed
WO-1998000405-A1 PHARMACEUTICAL PREPARATION MERCK & CO., INC. (US) 1998-01-08 WO disclosed
WO-1997049690-A1 A METHOD FOR TREATING MENIERE'S DISEASE MERCK & CO., INC. (US) 1997-12-31 WO disclosed
CN-1142184-A Antiarrhythmic benzodiazepines * MERCK & CO INC (US) 1997-02-05 CN disclosed
US-5595990-A TREATMENT OF CARDIOVASCULAR DISORDERS MERCK & CO., INC. (US) 1997-01-21 US disclosed
EP-0730454-A1 ANTIARRHYTHMIC BENZODIAZEPINES MERCK & CO. INC. (US) 1996-09-11 EP disclosed
US-5426185-A Antiarrhythmia agents having reduced side effects MERCK & CO., INC. (US) 1995-06-20 US disclosed
WO-1995014471-A1 ANTIARRHYTHMIC BENZODIAZEPINES MERCK & CO., INC. (US) 1995-06-01 WO disclosed